Su, F.; Wu, Y.; Li, J.; Huang, Y.; Yu, B.; Xu, L.; Xue, Y.; Xiao, C.; Yuan, X.
Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice. Vaccines 2021, 9, 266.
https://doi.org/10.3390/vaccines9030266
AMA Style
Su F, Wu Y, Li J, Huang Y, Yu B, Xu L, Xue Y, Xiao C, Yuan X.
Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice. Vaccines. 2021; 9(3):266.
https://doi.org/10.3390/vaccines9030266
Chicago/Turabian Style
Su, Fei, Yige Wu, Junxing Li, Yee Huang, Bin Yu, Lihua Xu, Yin Xue, Chenwen Xiao, and Xiufang Yuan.
2021. "Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice" Vaccines 9, no. 3: 266.
https://doi.org/10.3390/vaccines9030266
APA Style
Su, F., Wu, Y., Li, J., Huang, Y., Yu, B., Xu, L., Xue, Y., Xiao, C., & Yuan, X.
(2021). Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice. Vaccines, 9(3), 266.
https://doi.org/10.3390/vaccines9030266